STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
25.41
+0.47 (1.88%)
At close: Aug 12, 2026, 4:00 PM EDT
24.91
-0.50 (-1.97%)
After-hours: Aug 12, 2026, 7:47 PM EDT
STAAR Surgical Company Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, STAAR Surgical Company stock has a consensus rating of "Hold" and an average price target of $28.7. The average 1-year stock price forecast is 12.95% higher than the current stock price, while the lowest is $20 (-21.29%) and the highest is $40 (+57.42%).
Price Target: $28.7 (+12.95%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for STAAR Surgical Company stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 10 | 10 | 9 | 8 | 7 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 0 | 0 | 0 | 1 | 1 |
| Total | 12 | 11 | 11 | 11 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $32 | Buy | Maintains | $32 | +25.93% | Aug 5, 2026 |
| UBS | UBS | Sell Initiates $20 | Sell | Initiates | $20 | -21.29% | Jul 28, 2026 |
| Wedbush | Wedbush | Buy Reiterates $40 | Buy | Reiterates | $40 | +57.42% | Jul 21, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $33 | Hold | Maintains | $33 | +29.87% | Jul 17, 2026 |
| Needham | Needham | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Jul 17, 2026 |
Financial Forecast
Revenue This Year
334.93M
from 239.44M
Increased by 39.88%
Revenue Next Year
359.51M
from 334.93M
Increased by 7.34%
EPS This Year
0.74
from -0.17
EPS Next Year
0.99
from 0.74
Increased by 34.07%
EPS and Forward PE are based on non-GAAP adjusted numbers.